Fierce Biotech January 31, 2023
Joseph Keenan

Crown Bioscience continued its expansion plans by teaming up with JSR Life Sciences to acquire IndivuServe, a unit of Germany’s Indivumed, in a share purchase agreement. (Stock photo/Getty Images)

Crown Bioscience and JSR Life Sciences teamed up to acquire IndivuServe, a unit of Germany’s Indivumed, in a share purchase agreement.

Under terms of the deal, which is expected to close in April, IndivuServe will become a wholly owned subsidiary of preclinical services provider Crown Bioscience, and it includes all associated laboratory operations and staff located in Hamburg, Germany, and Frederick, Maryland.

IndivuServ combines high-quality biospecimens and clinical information to help partners in biomarker discovery and drug development in personalized oncology, the company said in a Jan. 25...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma / Biotech, Trends
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
Xaira, Anthos, CureVac & more—Chutes & Ladders

Share This Article